

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.28132193 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.28132193 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.91699936 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.91699936 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.24311452 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.67911963 |
| 7 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.38667479 |
| 8 | protein carboxylation (GO:0018214) | 5.38667479 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.35787422 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.35787422 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.35787422 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.30026931 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.28844632 |
| 14 | regulation of protein activation cascade (GO:2000257) | 5.21426067 |
| 15 | kynurenine metabolic process (GO:0070189) | 5.20213338 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.17697575 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.17035585 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.07107446 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.06971422 |
| 20 | epoxygenase P450 pathway (GO:0019373) | 5.05987020 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.05899054 |
| 22 | urea cycle (GO:0000050) | 5.04809829 |
| 23 | urea metabolic process (GO:0019627) | 5.04809829 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.00798894 |
| 25 | alpha-linolenic acid metabolic process (GO:0036109) | 5.00526533 |
| 26 | cysteine metabolic process (GO:0006534) | 4.99497555 |
| 27 | regulation of complement activation (GO:0030449) | 4.92475953 |
| 28 | ethanol metabolic process (GO:0006067) | 4.88477844 |
| 29 | bile acid metabolic process (GO:0008206) | 4.65835115 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.65675011 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.63987830 |
| 32 | tyrosine metabolic process (GO:0006570) | 4.59860837 |
| 33 | negative regulation of complement activation (GO:0045916) | 4.53703375 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.53312891 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.51480673 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.41676398 |
| 37 | regulation of plasminogen activation (GO:0010755) | 4.41255065 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.40043156 |
| 39 | exogenous drug catabolic process (GO:0042738) | 4.38150056 |
| 40 | serine family amino acid catabolic process (GO:0009071) | 4.37693486 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.32681209 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.32060488 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.32060488 |
| 44 | bile acid and bile salt transport (GO:0015721) | 4.28331649 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.27723531 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.27723531 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.27723531 |
| 48 | phospholipid efflux (GO:0033700) | 4.26008469 |
| 49 | omega-hydroxylase P450 pathway (GO:0097267) | 4.22921693 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.10092623 |
| 51 | lysine metabolic process (GO:0006553) | 4.06730089 |
| 52 | lysine catabolic process (GO:0006554) | 4.06730089 |
| 53 | coenzyme catabolic process (GO:0009109) | 4.02641802 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.01763276 |
| 55 | diacylglycerol metabolic process (GO:0046339) | 4.01739701 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.00462951 |
| 57 | negative regulation of sterol transport (GO:0032372) | 4.00376551 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.00376551 |
| 59 | cholesterol efflux (GO:0033344) | 4.00306688 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 3.97103077 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 3.91624633 |
| 62 | cellular glucuronidation (GO:0052695) | 3.89949315 |
| 63 | fibrinolysis (GO:0042730) | 3.87299203 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 3.82243397 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 3.81517848 |
| 66 | negative regulation of blood coagulation (GO:0030195) | 3.80111012 |
| 67 | negative regulation of hemostasis (GO:1900047) | 3.80111012 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 3.79150900 |
| 69 | intestinal cholesterol absorption (GO:0030299) | 3.74946239 |
| 70 | complement activation, classical pathway (GO:0006958) | 3.74328802 |
| 71 | amine catabolic process (GO:0009310) | 3.72411121 |
| 72 | cellular biogenic amine catabolic process (GO:0042402) | 3.72411121 |
| 73 | complement activation (GO:0006956) | 3.70798061 |
| 74 | regulation of humoral immune response (GO:0002920) | 3.69472962 |
| 75 | regulation of phospholipase A2 activity (GO:0032429) | 3.66879507 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.65779988 |
| 77 | regulation of apoptotic cell clearance (GO:2000425) | 3.64475985 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 3.64110272 |
| 79 | glutamate metabolic process (GO:0006536) | 3.63751162 |
| 80 | negative regulation of protein activation cascade (GO:2000258) | 3.62433604 |
| 81 | negative regulation of humoral immune response (GO:0002921) | 3.62425136 |
| 82 | negative regulation of coagulation (GO:0050819) | 3.60118061 |
| 83 | regulation of cholesterol homeostasis (GO:2000188) | 3.59331921 |
| 84 | protein activation cascade (GO:0072376) | 3.59242383 |
| 85 | opsonization (GO:0008228) | 3.58650654 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.54891264 |
| 87 | phenylpropanoid metabolic process (GO:0009698) | 3.54520739 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.54368230 |
| 89 | aldehyde catabolic process (GO:0046185) | 3.53534340 |
| 90 | phospholipid homeostasis (GO:0055091) | 3.53391689 |
| 91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.52637115 |
| 92 | primary alcohol catabolic process (GO:0034310) | 3.52277801 |
| 93 | glycine metabolic process (GO:0006544) | 3.51942445 |
| 94 | drug catabolic process (GO:0042737) | 3.50201596 |
| 95 | protein-lipid complex assembly (GO:0065005) | 3.48568379 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.48403000 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.48403000 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.47883062 |
| 99 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.47100146 |
| 100 | protein-lipid complex subunit organization (GO:0071825) | 3.46820181 |
| 101 | blood coagulation, intrinsic pathway (GO:0007597) | 3.45954052 |
| 102 | serine family amino acid metabolic process (GO:0009069) | 3.45741172 |
| 103 | ethanol oxidation (GO:0006069) | 3.44811617 |
| 104 | cofactor catabolic process (GO:0051187) | 3.44765989 |
| 105 | xenobiotic catabolic process (GO:0042178) | 3.44604761 |
| 106 | sterol homeostasis (GO:0055092) | 3.42706081 |
| 107 | organic acid catabolic process (GO:0016054) | 3.42206377 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.42206377 |
| 109 | ketone body metabolic process (GO:1902224) | 3.41447133 |
| 110 | negative regulation of wound healing (GO:0061045) | 3.39556886 |
| 111 | acute-phase response (GO:0006953) | 3.39476756 |
| 112 | lipoprotein metabolic process (GO:0042157) | 3.38202399 |
| 113 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.37668458 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.37668458 |
| 115 | positive regulation of lipid catabolic process (GO:0050996) | 3.37452425 |
| 116 | arginine metabolic process (GO:0006525) | 3.36304559 |
| 117 | cytolysis (GO:0019835) | 3.36053895 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.31007027 |
| 119 | plasma lipoprotein particle organization (GO:0071827) | 3.30998430 |
| 120 | drug metabolic process (GO:0017144) | 3.29633575 |
| 121 | short-chain fatty acid metabolic process (GO:0046459) | 3.27058942 |
| 122 | primary alcohol metabolic process (GO:0034308) | 3.25563712 |
| 123 | positive regulation of blood coagulation (GO:0030194) | 3.20550156 |
| 124 | positive regulation of hemostasis (GO:1900048) | 3.20550156 |
| 125 | intestinal absorption (GO:0050892) | 3.06308127 |
| 126 | positive regulation of coagulation (GO:0050820) | 3.05753905 |
| 127 | sterol transport (GO:0015918) | 3.02357988 |
| 128 | cholesterol transport (GO:0030301) | 3.02357988 |
| 129 | heme transport (GO:0015886) | 2.99219324 |
| 130 | acute inflammatory response (GO:0002526) | 2.97301889 |
| 131 | doxorubicin metabolic process (GO:0044598) | 2.89621110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.64373321 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.52600025 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10671307 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.08832776 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.87492054 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.67497332 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.30679116 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76891694 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.51057935 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.40478330 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.09263681 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5866700 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96446203 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.89325133 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88931140 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85509358 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.82620044 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.73583318 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65399774 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55568992 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55437715 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36411856 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34393648 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.33540435 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29990763 |
| 26 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29604636 |
| 27 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27598540 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24010041 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21973946 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20136823 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15338566 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15215439 |
| 33 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.14478000 |
| 34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12249905 |
| 35 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.09275015 |
| 36 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06088046 |
| 37 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05732805 |
| 38 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05122586 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04840791 |
| 40 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03336752 |
| 41 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03316357 |
| 42 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00127715 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99957911 |
| 44 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99633230 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98420856 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98350966 |
| 47 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96594528 |
| 48 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96279023 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96279023 |
| 50 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96200819 |
| 51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92637519 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90912651 |
| 53 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90678104 |
| 54 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90633727 |
| 55 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88864768 |
| 56 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88604907 |
| 57 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.87667320 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87446086 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86687965 |
| 60 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86340325 |
| 61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85415128 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84644797 |
| 63 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.83507699 |
| 64 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.83267779 |
| 65 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82339269 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82130251 |
| 67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.81324694 |
| 68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80092439 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.79736534 |
| 70 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77532715 |
| 71 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.77182269 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.77167271 |
| 73 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.76561423 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.76120453 |
| 75 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75175246 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.74830905 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74830905 |
| 78 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73162298 |
| 79 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.73054396 |
| 80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.72269062 |
| 81 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.71996135 |
| 82 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71902434 |
| 83 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.71877889 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71757154 |
| 85 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.68876795 |
| 86 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.68704367 |
| 87 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.68367394 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.68367394 |
| 89 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68088166 |
| 90 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.67863745 |
| 91 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67336384 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67227921 |
| 93 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.66939066 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.65170703 |
| 95 | AR_20517297_ChIP-Seq_VCAP_Human | 0.64933131 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64750946 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64335107 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.64295957 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63252249 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.62446662 |
| 101 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62115865 |
| 102 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61031087 |
| 103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.60836383 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60191821 |
| 105 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59603307 |
| 106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58322951 |
| 107 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58261482 |
| 108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.57270472 |
| 109 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.56883174 |
| 110 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.56432406 |
| 111 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56269540 |
| 112 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.56065073 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.53567127 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53249745 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53235887 |
| 116 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.52811205 |
| 117 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.52811205 |
| 118 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52606935 |
| 119 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.50782647 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.50315345 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.50268588 |
| 122 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.49771085 |
| 123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49654218 |
| 124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.49471914 |
| 125 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.49245559 |
| 126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.48968509 |
| 127 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48912485 |
| 128 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.48046179 |
| 129 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46387461 |
| 130 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.46155182 |
| 131 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.46014165 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45828047 |
| 133 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44952436 |
| 134 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.44937409 |
| 135 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.44357362 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44173592 |
| 137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.43308178 |
| 138 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43214628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.45730745 |
| 2 | MP0005360_urolithiasis | 6.45410599 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.96931418 |
| 4 | MP0005365_abnormal_bile_salt | 5.89546878 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.58894999 |
| 6 | MP0003252_abnormal_bile_duct | 3.90945782 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.56757120 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.25099897 |
| 9 | MP0005083_abnormal_biliary_tract | 3.21208321 |
| 10 | MP0003195_calcinosis | 3.19104397 |
| 11 | MP0009840_abnormal_foam_cell | 3.15452007 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.76942943 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.60639358 |
| 14 | MP0005332_abnormal_amino_acid | 2.50659638 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.21947700 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.06435367 |
| 17 | MP0000609_abnormal_liver_physiology | 2.06022584 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.99870373 |
| 19 | MP0003868_abnormal_feces_composition | 1.96524254 |
| 20 | MP0004272_abnormal_basement_membrane | 1.83228528 |
| 21 | MP0002132_abnormal_respiratory_system | 1.77806258 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.64673765 |
| 23 | MP0001764_abnormal_homeostasis | 1.48619020 |
| 24 | MP0005220_abnormal_exocrine_pancreas | 1.47088296 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.46665528 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 1.45421152 |
| 27 | MP0003122_maternal_imprinting | 1.35796093 |
| 28 | MP0010368_abnormal_lymphatic_system | 1.32965163 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32100362 |
| 30 | MP0009697_abnormal_copulation | 1.16731236 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.13453551 |
| 32 | MP0002254_reproductive_system_inflammat | 1.11255289 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.10810931 |
| 34 | MP0003186_abnormal_redox_activity | 1.10757513 |
| 35 | MP0000598_abnormal_liver_morphology | 1.10230716 |
| 36 | MP0008438_abnormal_cutaneous_collagen | 1.09202252 |
| 37 | MP0002078_abnormal_glucose_homeostasis | 1.08964358 |
| 38 | MP0003950_abnormal_plasma_membrane | 1.07478479 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.05587455 |
| 40 | MP0003879_abnormal_hair_cell | 1.05327295 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.05190746 |
| 42 | MP0005670_abnormal_white_adipose | 1.02145415 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.01817832 |
| 44 | MP0005164_abnormal_response_to | 0.99419796 |
| 45 | MP0005408_hypopigmentation | 0.96124275 |
| 46 | MP0001756_abnormal_urination | 0.93236296 |
| 47 | MP0009764_decreased_sensitivity_to | 0.92718415 |
| 48 | MP0008004_abnormal_stomach_pH | 0.92485371 |
| 49 | MP0000604_amyloidosis | 0.92132488 |
| 50 | MP0005451_abnormal_body_composition | 0.92106564 |
| 51 | MP0009763_increased_sensitivity_to | 0.91824435 |
| 52 | MP0009642_abnormal_blood_homeostasis | 0.91643972 |
| 53 | MP0003724_increased_susceptibility_to | 0.91625255 |
| 54 | MP0008469_abnormal_protein_level | 0.91279838 |
| 55 | MP0005647_abnormal_sex_gland | 0.91247856 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 0.90823750 |
| 57 | MP0001944_abnormal_pancreas_morphology | 0.90794408 |
| 58 | MP0003011_delayed_dark_adaptation | 0.88529308 |
| 59 | MP0005646_abnormal_pituitary_gland | 0.88411480 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 0.84862860 |
| 61 | MP0009115_abnormal_fat_cell | 0.84260484 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 0.82904078 |
| 63 | MP0002928_abnormal_bile_duct | 0.82363145 |
| 64 | MP0002693_abnormal_pancreas_physiology | 0.78867088 |
| 65 | MP0005334_abnormal_fat_pad | 0.76776062 |
| 66 | MP0005275_abnormal_skin_tensile | 0.75966627 |
| 67 | MP0000003_abnormal_adipose_tissue | 0.75111159 |
| 68 | MP0001661_extended_life_span | 0.73568809 |
| 69 | MP0000013_abnormal_adipose_tissue | 0.73038085 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.72726586 |
| 71 | MP0002971_abnormal_brown_adipose | 0.71297899 |
| 72 | MP0005410_abnormal_fertilization | 0.71101291 |
| 73 | MP0001270_distended_abdomen | 0.70460540 |
| 74 | MP0005535_abnormal_body_temperature | 0.69659870 |
| 75 | MP0002060_abnormal_skin_morphology | 0.68869033 |
| 76 | MP0009384_cardiac_valve_regurgitation | 0.68843506 |
| 77 | MP0004130_abnormal_muscle_cell | 0.68626892 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.67898414 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.67534940 |
| 80 | MP0000639_abnormal_adrenal_gland | 0.67347692 |
| 81 | MP0003172_abnormal_lysosome_physiology | 0.66638812 |
| 82 | MP0001915_intracranial_hemorrhage | 0.65412472 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 0.65112603 |
| 84 | MP0005448_abnormal_energy_balance | 0.64742333 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.63185199 |
| 86 | MP0004043_abnormal_pH_regulation | 0.62768566 |
| 87 | MP0005375_adipose_tissue_phenotype | 0.61451709 |
| 88 | MP0001501_abnormal_sleep_pattern | 0.61430284 |
| 89 | MP0003690_abnormal_glial_cell | 0.61298618 |
| 90 | MP0003953_abnormal_hormone_level | 0.59484974 |
| 91 | MP0003436_decreased_susceptibility_to | 0.59331478 |
| 92 | MP0002877_abnormal_melanocyte_morpholog | 0.59234218 |
| 93 | MP0001984_abnormal_olfaction | 0.59143823 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.58036489 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.57943617 |
| 96 | MP0002295_abnormal_pulmonary_circulatio | 0.57552514 |
| 97 | MP0005166_decreased_susceptibility_to | 0.56553979 |
| 98 | MP0006036_abnormal_mitochondrial_physio | 0.55458339 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.55381964 |
| 100 | MP0003315_abnormal_perineum_morphology | 0.54864327 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.53686130 |
| 102 | MP0002168_other_aberrant_phenotype | 0.53683559 |
| 103 | MP0001243_abnormal_dermal_layer | 0.51268468 |
| 104 | MP0002933_joint_inflammation | 0.51232599 |
| 105 | MP0005379_endocrine/exocrine_gland_phen | 0.50781111 |
| 106 | MP0003633_abnormal_nervous_system | 0.50277009 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.50078297 |
| 108 | MP0006082_CNS_inflammation | 0.49665689 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.49566331 |
| 110 | MP0005187_abnormal_penis_morphology | 0.49489042 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.48385068 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.47953664 |
| 113 | MP0003075_altered_response_to | 0.46857126 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.45459885 |
| 115 | MP0006054_spinal_hemorrhage | 0.44870640 |
| 116 | MP0009053_abnormal_anal_canal | 0.44417907 |
| 117 | MP0010234_abnormal_vibrissa_follicle | 0.44033256 |
| 118 | MP0001765_abnormal_ion_homeostasis | 0.43988038 |
| 119 | MP0000249_abnormal_blood_vessel | 0.43909503 |
| 120 | MP0005395_other_phenotype | 0.43645347 |
| 121 | MP0003959_abnormal_lean_body | 0.42300048 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.41445194 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.40279649 |
| 124 | MP0004883_abnormal_blood_vessel | 0.39570150 |
| 125 | MP0005023_abnormal_wound_healing | 0.39544169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.29116354 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.69587360 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.67280745 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.10862935 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.02291664 |
| 6 | Complement deficiency (HP:0004431) | 5.73166405 |
| 7 | Xanthomatosis (HP:0000991) | 5.70738524 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.35686382 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.97415194 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.87151508 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.65169795 |
| 12 | Joint hemorrhage (HP:0005261) | 4.47671314 |
| 13 | Ketosis (HP:0001946) | 4.28544087 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 4.25837404 |
| 15 | Abnormality of complement system (HP:0005339) | 4.22653761 |
| 16 | Hypolipoproteinemia (HP:0010981) | 4.21113451 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 3.99810032 |
| 18 | Epidermoid cyst (HP:0200040) | 3.99119834 |
| 19 | Fat malabsorption (HP:0002630) | 3.93093773 |
| 20 | Hyperammonemia (HP:0001987) | 3.89899613 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.88793979 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.87431539 |
| 23 | Hypoglycemic seizures (HP:0002173) | 3.81034145 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.74488750 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.70181112 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 3.68268880 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.66879907 |
| 28 | Ketoacidosis (HP:0001993) | 3.66387553 |
| 29 | Hyperglycinemia (HP:0002154) | 3.63446057 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.54489548 |
| 31 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.45774379 |
| 32 | Hyperglycinuria (HP:0003108) | 3.31365704 |
| 33 | Glomerulonephritis (HP:0000099) | 3.24209745 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.22149065 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.19847770 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18621379 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.18621379 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.08232134 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.07516944 |
| 40 | Skin nodule (HP:0200036) | 3.04020936 |
| 41 | Myocardial infarction (HP:0001658) | 2.96149520 |
| 42 | Hyperglycemia (HP:0003074) | 2.94683729 |
| 43 | Late onset (HP:0003584) | 2.92098365 |
| 44 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.91946652 |
| 45 | Steatorrhea (HP:0002570) | 2.86787226 |
| 46 | Symptomatic seizures (HP:0011145) | 2.83563069 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.80379936 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.80004876 |
| 49 | Gout (HP:0001997) | 2.74708718 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.74033988 |
| 51 | Spontaneous abortion (HP:0005268) | 2.68280425 |
| 52 | Mitral stenosis (HP:0001718) | 2.58120572 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.56632506 |
| 54 | Delayed CNS myelination (HP:0002188) | 2.55145622 |
| 55 | Amyloidosis (HP:0011034) | 2.47600112 |
| 56 | Metabolic acidosis (HP:0001942) | 2.46691221 |
| 57 | Abnormality of vitamin metabolism (HP:0100508) | 2.44130456 |
| 58 | Abnormality of serum amino acid levels (HP:0003112) | 2.42201052 |
| 59 | Pigmentary retinal degeneration (HP:0001146) | 2.42177836 |
| 60 | Hypophosphatemic rickets (HP:0004912) | 2.42090901 |
| 61 | Vascular calcification (HP:0004934) | 2.40161082 |
| 62 | Purpura (HP:0000979) | 2.39544816 |
| 63 | Generalized aminoaciduria (HP:0002909) | 2.36974673 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.34342091 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.34342091 |
| 66 | Irritability (HP:0000737) | 2.31269326 |
| 67 | Facial shape deformation (HP:0011334) | 2.29995583 |
| 68 | Potter facies (HP:0002009) | 2.29995583 |
| 69 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.27598364 |
| 70 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.27598364 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.23494738 |
| 72 | Abnormal gallbladder morphology (HP:0012437) | 2.23292496 |
| 73 | Abnormality of carpal bone ossification (HP:0006257) | 2.21916306 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21624150 |
| 75 | Pancreatitis (HP:0001733) | 2.17758893 |
| 76 | Esophageal varix (HP:0002040) | 2.17182449 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 2.16668046 |
| 78 | Glycosuria (HP:0003076) | 2.16668046 |
| 79 | Lethargy (HP:0001254) | 2.14586710 |
| 80 | Abnormal tarsal ossification (HP:0008369) | 2.14056146 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.11065285 |
| 82 | Nephritis (HP:0000123) | 2.10554232 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 2.10391692 |
| 84 | Menorrhagia (HP:0000132) | 2.09425350 |
| 85 | Gingival bleeding (HP:0000225) | 2.08066633 |
| 86 | Enlarged kidneys (HP:0000105) | 2.06680705 |
| 87 | Hypothermia (HP:0002045) | 2.06418942 |
| 88 | Arthropathy (HP:0003040) | 2.06161542 |
| 89 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.04990030 |
| 90 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.02785303 |
| 91 | Malnutrition (HP:0004395) | 2.01956109 |
| 92 | Brushfield spots (HP:0001088) | 1.94939213 |
| 93 | Osteomalacia (HP:0002749) | 1.94554873 |
| 94 | Spastic diplegia (HP:0001264) | 1.94245644 |
| 95 | Cholelithiasis (HP:0001081) | 1.92756038 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92030886 |
| 97 | Mucopolysacchariduria (HP:0008155) | 1.92030886 |
| 98 | Acanthocytosis (HP:0001927) | 1.91823877 |
| 99 | Opisthotonus (HP:0002179) | 1.91520054 |
| 100 | Neonatal onset (HP:0003623) | 1.91427780 |
| 101 | Retinal atrophy (HP:0001105) | 1.88051210 |
| 102 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87415690 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 1.86950776 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 1.84962942 |
| 105 | Hydroxyprolinuria (HP:0003080) | 1.84962942 |
| 106 | Alkalosis (HP:0001948) | 1.83948275 |
| 107 | Cerebral edema (HP:0002181) | 1.82879685 |
| 108 | Thrombophlebitis (HP:0004418) | 1.82374909 |
| 109 | Vomiting (HP:0002013) | 1.82225542 |
| 110 | Abnormality of the gallbladder (HP:0005264) | 1.80931733 |
| 111 | Insulin resistance (HP:0000855) | 1.78717061 |
| 112 | Abnormal ciliary motility (HP:0012262) | 1.78709924 |
| 113 | Joint swelling (HP:0001386) | 1.77535285 |
| 114 | Hemorrhage of the eye (HP:0011885) | 1.77255525 |
| 115 | Widely patent fontanelles and sutures (HP:0004492) | 1.77254031 |
| 116 | Rickets (HP:0002748) | 1.76396528 |
| 117 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76333446 |
| 118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76333446 |
| 119 | Vacuolated lymphocytes (HP:0001922) | 1.75324039 |
| 120 | Proximal tubulopathy (HP:0000114) | 1.75307007 |
| 121 | Bifid scrotum (HP:0000048) | 1.75124381 |
| 122 | Gonadal dysgenesis (HP:0000133) | 1.74215151 |
| 123 | Abnormal delivery (HP:0001787) | 1.72360523 |
| 124 | Testicular neoplasm (HP:0010788) | 1.70693856 |
| 125 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.64641075 |
| 126 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.64641075 |
| 127 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.61553456 |
| 128 | Increased serum pyruvate (HP:0003542) | 1.60867116 |
| 129 | Abnormal hand bone ossification (HP:0010660) | 1.60590950 |
| 130 | Hyperphosphaturia (HP:0003109) | 1.57677751 |
| 131 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.54417948 |
| 132 | Small epiphyses (HP:0010585) | 1.52597921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.16501059 |
| 2 | BCKDK | 5.03189035 |
| 3 | ERN1 | 4.74831738 |
| 4 | MYLK | 3.79650362 |
| 5 | MAPK15 | 3.69129635 |
| 6 | FGFR4 | 3.47236620 |
| 7 | TAOK3 | 3.26530097 |
| 8 | SIK1 | 3.21317683 |
| 9 | PIK3CG | 2.49066603 |
| 10 | TRIB3 | 2.45663711 |
| 11 | FRK | 2.44872828 |
| 12 | FLT3 | 2.15710197 |
| 13 | TGFBR2 | 2.15297216 |
| 14 | PKN2 | 1.87479930 |
| 15 | MST1R | 1.79206604 |
| 16 | ERBB4 | 1.70289382 |
| 17 | PTK6 | 1.67200958 |
| 18 | MAP4K2 | 1.66789285 |
| 19 | EPHA3 | 1.63591949 |
| 20 | LATS1 | 1.58218248 |
| 21 | IRAK3 | 1.56429082 |
| 22 | AKT3 | 1.51663969 |
| 23 | TYK2 | 1.47628755 |
| 24 | DDR2 | 1.43991461 |
| 25 | MAP3K3 | 1.41949344 |
| 26 | TRPM7 | 1.41856019 |
| 27 | EIF2AK3 | 1.40926647 |
| 28 | ACVR1B | 1.37513227 |
| 29 | NEK9 | 1.30196834 |
| 30 | SGK494 | 1.28426871 |
| 31 | SGK223 | 1.28426871 |
| 32 | MAP3K2 | 1.25137055 |
| 33 | MET | 1.16121004 |
| 34 | EPHB1 | 1.15433936 |
| 35 | MAPK11 | 1.14562950 |
| 36 | JAK1 | 1.09330462 |
| 37 | LATS2 | 1.08309336 |
| 38 | MARK3 | 1.08211832 |
| 39 | JAK2 | 1.07539230 |
| 40 | EEF2K | 1.07271043 |
| 41 | FGFR2 | 1.07268427 |
| 42 | TIE1 | 1.07240814 |
| 43 | MST4 | 1.05384734 |
| 44 | CSNK1G1 | 1.04328823 |
| 45 | MAP2K4 | 1.00088044 |
| 46 | MAP3K12 | 0.98982834 |
| 47 | STK39 | 0.97038802 |
| 48 | TBK1 | 0.95474156 |
| 49 | NEK2 | 0.94623778 |
| 50 | ADRBK2 | 0.94530056 |
| 51 | PDGFRA | 0.93982504 |
| 52 | KDR | 0.93556062 |
| 53 | ARAF | 0.93169552 |
| 54 | MAP2K2 | 0.92252860 |
| 55 | IRAK1 | 0.91783055 |
| 56 | PTK2 | 0.91554389 |
| 57 | PHKG2 | 0.90750751 |
| 58 | PHKG1 | 0.90750751 |
| 59 | STK38 | 0.88957526 |
| 60 | CSK | 0.88752810 |
| 61 | OBSCN | 0.87571049 |
| 62 | FER | 0.84249892 |
| 63 | DYRK1B | 0.84233871 |
| 64 | CAMK1D | 0.84014936 |
| 65 | FGFR1 | 0.83962284 |
| 66 | STK38L | 0.83756673 |
| 67 | WNK3 | 0.83196847 |
| 68 | MOS | 0.81941551 |
| 69 | DAPK2 | 0.79164960 |
| 70 | PRKAA2 | 0.79079041 |
| 71 | PTK2B | 0.78790620 |
| 72 | MAP2K3 | 0.77170864 |
| 73 | GSK3A | 0.75828162 |
| 74 | CSNK1A1L | 0.74359132 |
| 75 | STK24 | 0.74248049 |
| 76 | MAP3K1 | 0.74192731 |
| 77 | RIPK1 | 0.73824405 |
| 78 | FGFR3 | 0.73805222 |
| 79 | PRKG1 | 0.71754486 |
| 80 | HIPK2 | 0.71454319 |
| 81 | LMTK2 | 0.71170229 |
| 82 | ABL2 | 0.70481027 |
| 83 | ZAP70 | 0.68755345 |
| 84 | MAP3K14 | 0.68571282 |
| 85 | STK3 | 0.66569531 |
| 86 | MAP3K13 | 0.65823612 |
| 87 | PDK1 | 0.65474872 |
| 88 | PASK | 0.63730486 |
| 89 | PRKCE | 0.61483129 |
| 90 | RPS6KB1 | 0.60839589 |
| 91 | CSNK1G3 | 0.60613688 |
| 92 | ERBB2 | 0.60047892 |
| 93 | ICK | 0.59266890 |
| 94 | BMPR1B | 0.58858135 |
| 95 | PINK1 | 0.57489156 |
| 96 | IGF1R | 0.56330568 |
| 97 | CDK6 | 0.54851215 |
| 98 | PRKACG | 0.54516397 |
| 99 | CDK3 | 0.53969715 |
| 100 | MAP3K7 | 0.53682672 |
| 101 | PRKCZ | 0.53627401 |
| 102 | RET | 0.53449483 |
| 103 | MAP2K1 | 0.53372883 |
| 104 | WNK4 | 0.52417969 |
| 105 | MAP3K5 | 0.50405957 |
| 106 | TNIK | 0.50345234 |
| 107 | EPHA2 | 0.50327737 |
| 108 | MAPK7 | 0.47840476 |
| 109 | PRKAA1 | 0.47291941 |
| 110 | NTRK1 | 0.46695093 |
| 111 | CSNK1G2 | 0.45960972 |
| 112 | MAP2K7 | 0.45532764 |
| 113 | MAPK4 | 0.44117738 |
| 114 | PDPK1 | 0.44089601 |
| 115 | GRK1 | 0.43059664 |
| 116 | MAPK12 | 0.41584700 |
| 117 | GRK5 | 0.40945265 |
| 118 | SGK3 | 0.40045113 |
| 119 | PRKACA | 0.38570416 |
| 120 | DAPK3 | 0.38208033 |
| 121 | MAP3K10 | 0.38178872 |
| 122 | CSF1R | 0.37782709 |
| 123 | IRAK2 | 0.37087859 |
| 124 | NLK | 0.37010172 |
| 125 | ITK | 0.37000198 |
| 126 | CSNK1A1 | 0.36869759 |
| 127 | MTOR | 0.36445833 |
| 128 | CAMK2D | 0.36322845 |
| 129 | PRKD1 | 0.34759208 |
| 130 | IKBKE | 0.33689429 |
| 131 | PRKCH | 0.32395107 |
| 132 | CAMK2G | 0.31986604 |
| 133 | PAK3 | 0.31647724 |
| 134 | GRK7 | 0.30697735 |
| 135 | PIK3CA | 0.30502808 |
| 136 | EGFR | 0.29730757 |
| 137 | CAMK1G | 0.28940608 |
| 138 | JAK3 | 0.28715385 |
| 139 | SGK2 | 0.27903918 |
| 140 | CHUK | 0.27839865 |
| 141 | NUAK1 | 0.26157898 |
| 142 | PDK2 | 0.25833937 |
| 143 | MAP2K6 | 0.25509004 |
| 144 | MAPKAPK3 | 0.25308505 |
| 145 | CDC42BPA | 0.23668505 |
| 146 | PRKG2 | 0.23578341 |
| 147 | PRKCQ | 0.23376719 |
| 148 | PAK2 | 0.23148611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29616665 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.44248811 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26600072 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.00627660 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.89626719 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78376686 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.73322354 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.50295173 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44463290 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.38254828 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35789862 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.31486797 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28573105 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25615501 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.11894955 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.04240506 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.00816950 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.99931167 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94280353 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87506792 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86219298 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.83888012 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82260378 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81225186 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79097863 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77500008 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74655536 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68570398 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.67909449 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60764653 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58269778 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57695845 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.57113320 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50810439 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48283692 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42029973 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.41232700 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41192829 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41093698 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.38762070 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.38136486 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30407041 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20439629 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.14086458 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.13554509 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06195878 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02686143 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91139920 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90152997 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88462233 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87533229 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87064868 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84146191 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.82269530 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.79025094 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78431744 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75787136 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72096705 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68478277 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65537117 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.61917104 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.60004575 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59456131 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58882602 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58319580 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53607703 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52042686 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48985614 |
| 69 | Protein export_Homo sapiens_hsa03060 | 0.48083073 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46281126 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.42131495 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42037553 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41790899 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41034545 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40822492 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40651661 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39253085 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37532824 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.36776225 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.31270778 |
| 81 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28274680 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27414396 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27394154 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26648776 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22273573 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19728609 |
| 87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19705521 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19030496 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.15387055 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15270742 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.14219588 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13354516 |
| 93 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09477648 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.07631153 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07355548 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.05752882 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.05733825 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03433554 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01618028 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.0830192 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0789236 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0545210 |
| 103 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0422745 |
| 104 | Pertussis_Homo sapiens_hsa05133 | -0.0313052 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0299550 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0208473 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0206790 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0174316 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0133176 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0124627 |

